Panacea Biotec Limited has submitted its quarterly compliance certificate to stock exchanges, confirming adherence to SEBI regulations governing depositories and participants for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 with both the National Stock Exchange of India Limited and BSE Limited on April 07, 2026. The certificate was issued by Skyline Financial Services Private Limited, which serves as the company's Registrar and Transfer Agent.

Compliance Confirmation

Skyline Financial Services Private Limited, in its capacity as Registrar and Transfer Agent, provided confirmation regarding the handling of physical share certificates received for dematerialization during the quarter. The certificate confirms two key compliance aspects:

• Securities comprised in the certificates have been listed on the Stock Exchange where earlier issued securities are listed
• Physical certificates have been properly mutilated and cancelled after due verification, with the depository name substituted in records as the registered owner within the mandated 15-day period

Corporate Information

The filing includes standard corporate identification details, with the company's Corporate Identification Number listed as L33117PB1984PLC022350. The submission was digitally signed by Ankit Jain, who holds the position of General Manager – Legal & Company Secretary, with the digital signature timestamp showing April 07, 2026 at 10:26:30 +05'30'.

This quarterly compliance filing represents part of the company's ongoing regulatory obligations under SEBI's framework for depositories and participants, ensuring proper handling and processing of share dematerialization requests.

Panacea Biotec Limited has filed its monthly share dematerialization report for March 2026 with stock exchanges and depositories, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

No Dematerialization Activity in March 2026

The company reported that no shares were dematerialized during March 2026. This information was communicated to the National Stock Exchange of India Limited, BSE Limited, National Securities Depository Limited (NSDL), and Central Depository Services (India) Limited (CDSL) on April 07, 2026.

Total Dematerialized Share Position

As of March 31, 2026, the total number of dematerialized shares remained unchanged at 6,11,04,526. The distribution across depositories is as follows:

Monthly Movement Analysis

The registrar and transfer agent, Skyline Financial Services Private Limited, provided a detailed comparison of holdings between February 28, 2026, and March 31, 2026:

The data shows internal transfers between the two depositories during March 2026, with NSDL gaining shares while CDSL's holding decreased by a corresponding amount, keeping the total unchanged.

Regulatory Compliance

The submission was made in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and CDSL's Operating Instructions for Issuers. The report was signed by Ankit Jain, General Manager – Legal & Company Secretary, and certified by Skyline Financial Services Private Limited as the company's registrar and transfer agent.

The company has maintained transparency in its dematerialization reporting process, providing detailed breakdowns and third-party certification to ensure accuracy of the submitted data.